| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Clearside Biomedical (NASDAQ:CLSD) stock rose 9.22% to $2.25 during Wednesday's after-market session. At the close, Clearside Biomedical's trading volume reached 25.2K shares. This is 14.84% of its average volume over the last 100 days. The market value of their outstanding shares is at $108.7 million.
Omeros (NASDAQ:OMER) stock increased by 8.28% to $13.46. Today's trading volume for this security ended up closing at 22.9K shares, which is 2.34 percent of its average volume over the last 100 days. The company's market cap stands at $829.8 million.
Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 4.02% to $2.07. Adial Pharmaceuticals's trading volume hit 572 shares by close, accounting for 0.02% of its average volume over the last 100 days. The market value of their outstanding shares is at $29.7 million.
Lumos Pharma (NASDAQ:LUMO) stock increased by 3.83% to $15.97. Today's trading volume for this security ended up closing at 200 shares, which is 1.75 percent of its average volume over the last 100 days. The company's market cap stands at $132.5 million.
Trxade Group (NASDAQ:MEDS) shares increased by 3.65% to $5.11. At the close, Trxade Group's trading volume reached 120 shares. This is 0.02% of its average volume over the last 100 days. The company's market cap stands at $41.3 million.
MannKind (NASDAQ:MNKD) shares increased by 3.47% to $2.98. Trading volume for this security closed at 75.9K, accounting for 2.81% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $693.1 million.
Acorda Therapeutics (NASDAQ:ACOR) stock declined by 7.82% to $0.76 during Wednesday's after-market session. Acorda Therapeutics's trading volume hit 568.6K shares by close, accounting for 9.22% of its average volume over the last 100 days. The company's market cap stands at $36.2 million.
Novus Therapeutics (NASDAQ:NVUS) shares fell 7.62% to $21.6. Novus Therapeutics's trading volume hit 103.2K shares by close, accounting for 49.33% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.0 million.
Tyme Technologies (NASDAQ:TYME) shares decreased by 5.36% to $1.06. At the close, Tyme Technologies's trading volume reached 3.2K shares. This is 0.85% of its average volume over the last 100 days. The company's market cap stands at $137.9 million.
Merrimack Pharmaceuticals (NASDAQ:MACK) shares fell 4.94% to $6.17. Trading volume for this security closed at 570.4K, accounting for 1487.57% of its average full-day volume over the last 100 days. The company's market cap stands at $82.5 million.
Acasti Pharma (NASDAQ:ACST) stock decreased by 4.69% to $0.3. Trading volume for this security closed at 189.2K, accounting for 2.54% of its average full-day volume over the last 100 days. The company's market cap stands at $29.5 million.
NanoVibronix (NASDAQ:NAOV) shares declined by 4.55% to $1.05. Today's trading volume for this security ended up closing at 91.0K shares, which is 2.09 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $14.0 million.
Posted In: ACOR ACST ADIL CLSD LUMO MACK MEDS MNKD NAOV NVUS OMER TYME
